Assignee
GENTA INC
US·30 granted patents·4 pending applications·1,377 citations·filing 1992–2010
Top patents by PatentIndex Score
34 records- 0196US6060456AChimeric oligonucleoside compoundsGENTA INC·Filed 1997·Granted May 9, 2000·218 cites·38 claims
- 0293US6028188ASynthetic oligomers having chirally pure phosphonate internucleosidyl linkages mixed with non-phosphonate internucleosidyl linkagesGENTA INC·Filed 1994·Granted Feb 22, 2000·251 cites·23 claims
- 0392US6262036B1Method for inhibiting RNA translation using chimeric oligonucleoside compoundsGENTA INC·Filed 2000·Granted Jul 17, 2001·41 cites·36 claims
- 0490US5783683AAntisense oligonucleotides which reduce expression of the FGFRI geneGENTA INC·Filed 1995·Granted Jul 21, 1998·133 cites·6 claims
- 0588US7354952B2Pharmaceutical gallium compositions and methodsGENTA INC·Filed 2006·Granted Apr 8, 2008·11 cites·20 claims
- 0688US5877220AAmide-based oligomeric cationic lipidsGENTA INC·Filed 1997·Granted Mar 2, 1999·71 cites·37 claims
- 0786US7119217B2Tri(alkylcarboxylato)gallium (III) products and pharmaceutical compositions containing themGENTA INC·Filed 2003·Granted Oct 10, 2006·20 cites·58 claims
- 0886US7060690B2Methods and compositions for treating a cell-proliferative disorder using CRE decoy oligomers, BCL-2 antisense oligomers, and hybrid oligomers thereofGENTA INC·Filed 2002·Granted Jun 13, 2006·17 cites·48 claims
- 0986US6020526AAmide-based cationic lipidsGENTA INC·Filed 1996·Granted Feb 1, 2000·73 cites·11 claims
- 1086US5616337AUnit dose skin care packageGENTA INC·Filed 1995·Granted Apr 1, 1997·120 cites·13 claims
- 1185US5958901APhosphonic acid-based cationic lipidsGENTA INC·Filed 1996·Granted Sep 28, 1999·64 cites·9 claims
- 1284US7456215B2Pharmaceutical gallium compositions and methodsGENTA INC·Filed 2008·Granted Nov 25, 2008·6 cites·20 claims
- 1381US5986083ASynthetic oligomers having phosphonate internucleosidyl linkages of undefined chirality mixed with non-phosphonate internucleosidyl linkagesGENTA INC·Filed 1994·Granted Nov 16, 1999·46 cites·21 claims
- 1480US7842724B2Pharmaceutical gallium compositions and methodsGENTA INC·Filed 2008·Granted Nov 30, 2010·3 cites·11 claims
- 1580US6005094AOligonucleotide analogues having improved stability at acid pHGENTA INC·Filed 1994·Granted Dec 21, 1999·44 cites·15 claims
- 1672US5877160ACompositions and methods of treatment of androgen-associated baldness using antisense oligomersGENTA INC·Filed 1995·Granted Mar 2, 1999·45 cites·35 claims
- 1771US5789576AMethylphosphonate dimer synthesisGENTA INC·Filed 1994·Granted Aug 4, 1998·25 cites·30 claims
- 1870US5854410AOligonucleoside cleavage compounds and therapiesGENTA INC·Filed 1994·Granted Dec 29, 1998·31 cites·2 claims
- 1970US5606049AMethod of preparing 2'-O-methyl cytidine monomers useful in oligomer synthesisGENTA INC·Filed 1992·Granted Feb 25, 1997·23 cites·2 claims
- 2067US5936080ACompositions and methods for the synthesis of organophosphorus derivativesGENTA INC·Filed 1996·Granted Aug 10, 1999·26 cites·23 claims
- 2167US5723599AOrganic polymer reagents for solid phase synthesis of oligonucleotidesGENTA INC·Filed 1995·Granted Mar 3, 1998·22 cites·21 claims
- 2266US5837856AChirally enriched synthetic phosphonate oligomersGENTA INC·Filed 1997·Granted Nov 17, 1998·20 cites·22 claims
- 2365US5955597AChirally enriched synthetic phosphate oligomersGENTA INC·Filed 1997·Granted Sep 21, 1999·19 cites·20 claims
- 2464US2006275308A1Combination of gallium compounds with nonchemotherapeutic anticancer agents in the treatment of neoplasiaGENTA INC·Filed 2006·Application pending·0 cites
- 2563US5792615ASynthetic oligomers having chirally pure phoshonate internucleosidyl linkages mixed with non-phosphonate internucleosidyl linkagesGENTA INC·Filed 1997·Granted Aug 11, 1998·21 cites·20 claims
- 2657US7795232B1Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomersGENTA INC·Filed 2000·Granted Sep 14, 2010·1 cites·14 claims
- 2757US5811538AProcess for the purification of oligomersGENTA INC·Filed 1994·Granted Sep 22, 1998·20 cites·31 claims
- 2853US7855183B2Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomersGENTA INC·Filed 2003·Granted Dec 21, 2010·0 cites·1 claims
- 2952US2009275655A1Pharmaceutical Gallium Compositions and MethodsGENTA INC·Filed 2009·Application pending·0 cites
- 3052US2009275654A1Pharmaceutical Gallium Compositions and MethodsGENTA INC·Filed 2009·Application pending·0 cites
- 3149US7256284B2Inhibitory oligonucleotides targeted to Bcl-2GENTA INC·Filed 2003·Granted Aug 14, 2007·0 cites·8 claims
- 3247US5726300AProcess for the synthesis of oligonucleotides and analogs with low water oxidation stepGENTA INC·Filed 1994·Granted Mar 10, 1998·6 cites·28 claims
- 3337US2010216867A1Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomersGENTA INC·Filed 2010·Application pending·0 cites
- 3430US5859234A2'-O-methyl cytidine monomer useful in oligonucleotide synthesisGENTA INC·Filed 1996·Granted Jan 12, 1999·0 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when GENTA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →